ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Oct. 26, 2022 /PRNewswire/ - ESSA Pharma Inc. (ESSA, or the Company) (NASDAQ: EPIX), a ...
United States Comunidad Autonoma De Cataluna British Columbia Nan Hyung Hong Pharma Inc Ased Chimera
Source: businessinsider.com